CMUK Conference 2021 - Clinical Q & A - Hosted by Joel Rose

Joel Rose, Chief Executive Cardiomyopathy UK, hosts:
Dr William Bradlow (audio only)
Professor Perry Elliott, President of Cardiomyopathy UK
Professor Ruth Newbury-Ecob
Dr Sam Mohiddin
They respond to questions from throughout the conference:
01:01 - Do cardiomyopathies only affect the heart? Does it affect other organs?
03:13 - How can we make sure we get genetic testing? How often should you be retested?
05:59 - Dr Sam Mohiddin discusses retesting for new gene panels
08:13 - Can an ICD procedure be reversed when medical advances make them obsolete?
12:07 - What are your thoughts on pregnancy and DCM?
15:52 - What can be done to make it easier for GPs to detect cardiomyopathies?
20:30 - If someone with cardiomyopathy develops type 2 diabetes, will the drugs still work?
23:21 - Is there anything we know about ACM (ARVC) that we didn’t know last year?
25:42 - What are your views on gene therapy?
31:08 - What impact does hormone replacement therapy (HRT) have on cardiomyopathy?
33:58 - I have an EF of 27% - I’m tired. Is it the medication or heart failure?
38:20 - Can the COVID-19 vaccination worsen cardiomyopathy? What are the links with myocarditis?
43:36 - What are the most exciting prospects coming for cardiomyopathy?
Recorded for the Cardiomyopathy Conference 2021.
Find out more about what we do at www.cardiomyopathy.org